Benign urinary bladder masses: rare entities (2024)

Background

This study aimed to present the characteristics and outcomes of benign urinary bladder masses, as well as the characteristics of the patients diagnosed with such lesions.

Methods

A single-center, cross-sectional, retrospective study was conducted. The study involved patients who underwent transurethral resection of the primary bladder tumor over a four-year period (May 2017–2021) and were subsequently diagnosed with a benign bladder lesion.

Results

Out of 478 patients who underwent transurethral resection of the primary bladder tumor, 26 (5.4%) were diagnosed with a benign bladder lesion. The most common benign bladder lesion was urothelial papilloma (50%, 13 patients). The majority of patients with urothelial papilloma were men (76.9%) and had a history of smoking (61.5%). The mean age was 62years. Most were diagnosed accidentally (69.2%), while others presented with hematuria (23.1%) or dysuria (7.7%). Most urothelial papillomas had a macroscopic polypoid appearance (61.5%), and most of them were solitary (84.6%), with a mean size amounting to 1cm. Only one patient experienced a recurrence and developed papillary urothelial neoplasm of low malignant potential (PUNLMP). Cystitis cystica/glandularis and polypoid cystitis were the second most commonly diagnosed benign bladder lesion, each identified in 3 patients. Singular cases of leiomyoma, inflammatory myofibroblastic tumor, chondroma, paraganglioma, villous adenoma, eosinophilic cystitis (pseudotumor), and ectopic prostatic tissue are described.

Conclusion

Benign bladder lesions constitute a group of various rare entities that can clinically and radiologically mimic urothelial carcinoma, but mostly show a good prognosis and a low incidence of recurrence.

Urinary bladder masses are a common occurrence, with most of them being malignant tumors. Urothelial carcinoma is the most common histopathological type, accounting for 90% of diagnosed bladder neoplasms [1]. Several types of benign masses can develop in the urinary bladder, but these are uncommon and account for 1–5% of all bladder tumors. Benign urinary bladder masses can initially be confused for bladder cancer, as they exhibit similar clinical presentations and radiological features [2, 3]. A definitive diagnosis is made by histopathological examination of the resected specimen. Due to their rare occurrence, benign bladder tumors are underreported in literature. Most of the studies available in the literature describe single case reports or small case series reporting on these rare entities [4, 5].

The aim of our study was to present the characteristics and outcomes of benign urinary bladder masses, as well as the characteristics of the patients diagnosed with and treated for such lesions.

A single-center, retrospective, cross-sectional study was conducted. Our hospital’s Research Ethics Committee reviewed and approved the study protocol. Patients who underwent bladder tumor surgery at our hospital over the four-year period considered (May 2017–2021) and who were subsequently diagnosed with a benign bladder lesion were included in the study. Patients with malignant bladder tumors were excluded from the study. To protect patient confidentiality, each patient was assigned an identification number, and their identity remained anonymous throughout the study. The hospital’s electronic medical records were retrospectively reviewed for data acquisition purposes. The authors confirm the availability and accessibility of all original data reported in this study. The variables taken into account include demographic data (sex, age, smoking history, comorbidities), the initial presenting bladder tumor symptom (hematuria, dysuria, or incidental finding), histopathological findings of the resected bladder tumor tissue, the macroscopic appearance of the tumor, the number, size, and location of tumors described by the surgeon during transurethral resection, and recurrence rates during the follow-up period.

2.1 Statistical analysis

Categorical variables are described as whole numbers (n) and percentages (%). Continuous variables are presented as median and range, or as mean and standard deviation (SD). The normality of data distribution was verified using a Kolmogorov–Smirnov test. All statistical analyses were performed using IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY: IBM Corp.

During the four-year period considered, a total of 478 adult patients underwent transurethral resection of the primary bladder tumor at our hospital. Out of those 478 patients, 26 (5.4%) were diagnosed with a benign bladder lesion, thus meeting the inclusion criteria.

The most common benign bladder lesion was urothelial papilloma (50%, 13 patients). The characteristics of the patients diagnosed with urothelial papilloma and tumor characteristics are presented in Table 1. The majority of patients were middle-aged men with a history of smoking. Tumors tended to have a polypoid appearance, and they were mostly asymptomatic, solitary, and small in size. Only one out of said 13 patients experienced a recurrence and developed papillary urothelial neoplasm of low malignant potential (PUNLMP), which was diagnosed during a follow-up cystoscopy performed nine months after the initial transurethral surgery. No recurrences or progressions have been identified during the subsequent follow-up period. Follow-ups with a regular annual cystoscopy are still ongoing for all patients.

Cystitis cystica/glandularis and polypoid cystitis were the second most commonly diagnosed benign bladder lesions, with each lesion being identified in 3 patients. A detailed summary of the patients' characteristics and lesion features is presented in Table 2. Two patients with cystitis cystica/glandularis presented with dysuria and had a history of recurrent urinary tract infections (UTIs), while the third patient presented with hematuria and had a chronic indwelling urinary catheter. Among the two symptomatic patients with papillary cystitis, one had a history of recurrent UTIs, and the other had undergone pelvic irradiation for prostate cancer.

The remaining 7 patients represent isolated cases of rare histopathological entities. Singular cases of leiomyoma, inflammatory myofibroblastic tumor, chondroma, non-functional paraganglioma, villous adenoma, eosinophilic cystitis (pseudotumor), and ectopic prostatic tissue are reported in Table 3. Only the patient diagnosed with non-functional paraganglioma was found to have a recurrence during their follow-up cystoscopy performed 3months after the initial resection. This finding may indicate that the lesion was not completely resected during the initial surgery. A repeated resection of the tumor was thus performed, confirming the initial diagnosis. No recurrences have been identified during the subsequent follow-up period. The origin of the villous adenoma was found to be a urachal diverticulum, and the patient was thus subjected to the resection of the diverticulum and the underlying portion of the bladder. A histopathological examination of the resected specimen confirmed the initial diagnosis. All five patients diagnosed with a benign tumor are scheduled for continuous follow-ups with an annual cystoscopy, while others are being followed up with regular urological examinations.

Urothelial papilloma is a rare type of benign bladder neoplasm that tends to affect men more than women and is usually diagnosed at a younger age compared to urothelial carcinoma [6,7,8]. In our study, more than 75% of patients with urothelial papilloma were male, and the mean age was 62years, which is lower than the average age for bladder cancer diagnosis reported by the American Cancer Society (73years) [9]. In our study, more than two thirds of urothelial papilloma cases were detected incidentally by ultrasound performed for other reasons, while the rest of the patients presented with hematuria or dysuria. In contrast, bladder cancer presents with hematuria in more than 80% of cases [10]. Most urothelial papillomas are solitary and relatively small tumors, although multifocality has been reported [6,7,8]. Our results also showed a predominance of solitary papillomas, with a mean average size of 1cm. Only two out of 13 patients had multifocal masses. The reported recurrence rate of urothelial papilloma in the literature ranges from 4 to 9%, with progression rates to high-grade carcinoma ranging from 2 to 9% [6,7,8]. In our study, only one out of 13 patients experienced a recurrence and developed PUNLMP. Different authors recommend various surveillance programs due to a small, but existing risk of recurrence and progression [5,6,7]. Therefore, our patients are scheduled to undergo annual follow-ups with cystoscopy.

Cystitis cystica/glandularis and papillary cystitis were the second most commonly diagnosed benign bladder lesions. Cystitis cystica/glandularis arises from the cystic overgrowth of von Brunn nests, i.e. invagin*tions of the urothelial surface. Papillary cystitis is a reactive proliferative lesion resulting from inflammation and edema in the lamina propria. These lesions are usually associated with chronic irritation or inflammation of the bladder, although their exact cause may remain unclear [11, 12]. Five out of six cases in our study were associated with recurrent UTIs, chronic indwelling urinary catheterization, or pelvic irradiation. Cystitis cystica/glandularis and papillary cystitis are common, but often asymptomatic, and they thus mostly remain undetected. In rare cases, they can mimic bladder cancer by presenting with symptoms such as dysuria, hematuria, or incidentally detected bladder masses on imaging. The potential precancerous nature of cystitis cystica/glandularis is a topic of debate, as some studies indicate an elevated risk of bladder cancer, while others do not support this claim. Papillary cystitis is a benign lesion with no malignant potential. Urologists should be aware of these lesions to avoid misdiagnosis, and more research is needed to clarify their clinical implications [11,12,13].

During our study period, we were able to identify and report on seven singular cases of benign bladder lesions that presented as a bladder mass. Bladder leiomyoma is a rare tumor with a higher incidence in females. It has an excellent prognosis with no reported cases of malignant transformation after surgical treatment [14]. Our study involved a 60-year-old female patient who presented with a solitary, solid bladder mass measuring 1.5cm, incidentally detected via ultrasound. After complete transurethral resection, the patient showed no recurrence during the follow-up period. Inflammatory myofibroblastic tumors mainly occur in the lungs but may, in rare cases, also be found in the urinary bladder. While most of said tumors are considered benign, some may have malignant potential. The prognosis is relatively good, with a low risk of distant metastases and a local tumor recurrence rate of only 4% after surgery [15]. Our study involved a 39-year-old male who presented with hematuria, and the tumor was a solid, solitary mass measuring 3.5cm. The patient did not experience any recurrence during the follow-up period.

Extra-skeletal chondromas are rare benign tumors composed of mature hyaline cartilage, with genitourinary chondromas being even rarer. There have only been a few reported cases of bladder chondromas, all in women in their sixth to eighth decade of life. Transurethral resection is an effective management strategy, although ongoing surveillance is recommended due to reported local recurrence rates [16]. One of our patients was a 59-year-old woman with an ultrasound finding that pointed to a bladder tumor. Endoscopically, two small masses were detected and resected, and the patient remained recurrence-free during the follow-up period.

Heterotopic pheochromocytoma, also known as paraganglioma, is a rare tumor that arises from sympathetic ganglia. Paraganglioma of the urinary bladder is extremely rare, occurring more commonly in females. It can be functional (i.e. secrete catecholamines) or non-functional. Only 10% of cases are malignant. Symptoms are often nonspecific, and surgical resection is the recommended treatment. Long-term follow-up is advised due to the possibility of recurrence and metastasis [17]. Our study included a 72-year-old asymptomatic woman who was incidentally found to have a 4cm solid bladder mass. After an initial resection, a recurrence was detected during a follow-up cystoscopy three months later, probably indicating an incomplete removal. A repeated resection confirmed the initial diagnosis, and no further recurrences were observed during the follow-up period.

Villous adenoma is rarely found in the urinary tract, with a predilection for the urachus, dome, and trigone in the bladder. It lacks specific diagnostic features on imaging or cystoscopy, and complete removal and thorough sampling are recommended so that no aggressive component is missed, as it may have malignant potential. Distinguishing it from adenocarcinoma is challenging, but isolated villous adenoma has an excellent prognosis after surgical resection, with rare recurrences [18]. Our study also identified a case of villous adenoma measuring 2.5cm in a 53-year-old woman with hematuria. The adenoma originated from a urachal diverticulum, and the patient underwent resection of both the diverticulum and the underlying portion of the bladder. The patient remained recurrence-free during the follow-up period.

Eosinophilic cystitis is a rare condition involving inflammation of the bladder, predominantly with eosinophils. In some cases, a bladder mass may be formed. Most cases have no apparent cause, but possible associations include a history of allergies, asthma, bacterial infections, and medication use [19]. Our study involved a 75-year-old male patient with multiple comorbidities and no known predisposing factors for eosinophilic cystitis, who presented with gross hematuria. Analyses revealed a large (4cm) solid bladder mass, which was completely resected. The patient remained asymptomatic during the follow-up period.

Ectopic prostatic tissue is a rare condition mainly affecting young males. Bladder polyps are a rare presentation of this condition, with less than 50 cases reported to date. It is important to be aware of this condition, as it may be mistaken for a neoplastic process [20]. Our study involved a 66-year-old asymptomatic man with an incidentally found papillary bladder mass on the lateral wall of the bladder. After transurethral resection, a histopathological examination revealed benign ectopic prostatic tissue.

Even though our study adds to the limited literature on the characteristics and outcomes of benign bladder lesions, we do acknowledge its limitations. The small sample size, attributed to the low incidence of said lesions, limits the generalizability of our findings. Additionally, the retrospective and observational design of our study may have introduced biases and inaccuracies in data collection.

Benign bladder masses are rare entities that can clinically and radiologically mimic malignant bladder tumors, but they mostly show a good prognosis. Although rare, benign lesions need to be considered in the differential diagnosis of bladder masses to avoid overtreatment. A histopathological analysis is required to distinguish them from bladder cancer. The recurrence rate is generally low, but increases with incomplete resection. Therefore, the treatment should aim for complete resection, and regular follow-ups are advised for the purpose of monitoring possible recurrences [7, 14,15,16,17]. The findings of this study contribute to the limited literature concerning this topic and point to the need for further research for the purpose of understanding said rare entities better.

PUNLMP:

Papillary urothelial neoplasm of low malignant potential

UTI:

Urinary tract infection

Authors and Affiliations

1. Department of Urology, University Hospital Center Split, Šoltanska 1, Split, Croatia

   Dora Jakus,Ivan Jurić&Marijan Šitum

Contributions

DJ and MŠ conceived of the presented idea and designed the study protocol. DJ and IJ collected and analyzed data. MŠ supervised the project. DJ and IJ wrote the manuscript. All authors read and approved the final version of the manuscript.

Corresponding author

Correspondence to Dora Jakus.

Ethics approval and consent to participate

This study was approved by the Institutional Ethics Committee of University Hospital Center Split (Class: 500-03/23-01/89; Ref. No. 2181-147/01/06/LJ.Z.-23-02). Patient consent to participate was not required due to the retrospective design of the study.

Consent for Publication

Written informed consent for publication of details relating to individual participants was obtained from each patient.

Competing interests

The authors declare that they have no competing interests.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions